Spermatogenic immunoglobulin superfamily (SgIGSF) is a mouse protein belonging to the immunoglobulin superfamily expressed in the spermatogenic cells of seminiferous tubules. We produced a specific polyclonal antibody against SgIGSF. Western blot analysis of the testes from postnatal developing mice using this antibody demonstrated multiple immunopositive bands of 80-130 kDa, which increased in number and size with the postnatal age. Enzymatic N-glycolysis caused reduction in the size of these bands to 70 kDa, indicating that SgIGSF is a glycoprotein and its glycosylation pattern and extent are developmentally regulated. Immunohistochemical analysis of the adult testis demonstrated that SgIGSF was present in the spermatogenic cells in the earlier steps of spermatogenesis and increased in amount from intermediate spermatogonia through zygotene spermatocytes but was diminished in the steps from early pachytene spermatocytes through round spermatids. After meiosis, SgIGSF reappeared in step 7 spermatids and was present in the elongating spermatids until spermiation. The immunoreactivity was localized primarily on the cell membrane. Consistent with the findings in adult testes, the analysis of the developing testes revealed that SgIGSF was expressed separately in the spermatogenic cells in earlier and later phases. Sertoli cells had no expression of SgIGSF, whereas both SgIGSF immunoprecipitated from the testis lysate and produced in COS-7 cells was shown to bind to the surface of Sertoli cells in primary culture. These results suggested that SgIGSF on the surface of spermatogenic cells binds to some membrane molecules on Sertoli cells in a heterophilic manner and thereby may play diverse roles in the spermatogenesis.
INTRODUCTION
Spermatogenesis is the developmental process of spermatogenic germ cells. It is well established that this process is regulated by a variety of hormonal and local factors [1] [2] [3] . Another possible key factor of the regulation of spermatogenesis is direct interaction between spermatogenic 1 This work was supported by a grant-in-aid from the Ministry of Education, Science, and Culture of Japan. cells and Sertoli cells. The structural junctions formed between spermatogenic cells and Sertoli cells are reported to be the desmosome-like junction and the ectoplasmic specialization [3, 4] . The latter is localized in the apical regions of Sertoli cells, which attach spermatids with this junction. On the other hand, the desmosome-like junction attaches Sertoli cells with spermatogonia, spermatocytes, or round spermatids but not with elongating spermatids [3] . On a molecular basis, N-cadherin, a member of the adhesion molecule family, is expressed in the rat testis from 1 wk postpartum through adulthood. It is localized to the basal junctions between Sertoli cells, between Sertoli cells and spermatocytes, or between Sertoli cells and spermatids at the steps ϳ15-19, indicating that it plays roles in interSertoli and/or Sertoli-spermatogenic attachments [5, 6] . In contrast, E-cadherin is expressed in the germ cells of prenatal gonads or in the Sertoli cells at the age of 8 days but not in the spermatogenic cells in the adult testis [7] [8] [9] . Epithelial cellular adhesion molecule, which is common to most epithelial cells, has been reported to be expressed in spermatogenic cells, but its specific role in spermatogenesis remains unclear [10] .
Recently, we cloned a novel mouse cDNA expressed in the early steps of spermatogenic cells in the mouse testis [11] . The amino acid sequence predicted from this cDNA represented a transmembrane protein consisting of three immunoglobulin-like domains, a transmembrane domain, and a cytoplasmic domain, and hence we named this protein SgIGSF (spermatogenic immunoglobulin superfamily). SgIGSF was not expressed in Sertoli, peritubular myoid, or interstitial cells of the testis. The structure and localization of SgIGSF suggested that it functions as a cell adhesion molecule during the early steps of spermatogenesis.
In the present study, we produced a specific polyclonal antibody for SgIGSF and thereby examined the expression and localization of SgIGSF in the spermatogenic cells in the adult and developing mouse testes. Also, we demonstrated that SgIGSF specifically binds to the putative receptor molecules on the surface of Sertoli cells in a heterophilic manner.
MATERIALS AND METHODS

Animals and Tissue Preparation
Male Slc:ddY mice at the ages of newborn (0 day) to 6 wk and 10 wk and male WWv mice at 10 wk were purchased from Nippon SLC, Inc. (Hamamatsu, Japan) and grown under 12L:12D laboratory conditions. All procedures were performed according to the ''Guidelines for the Care and Use of Laboratory Animals'' at the Takara-machi Campus of Kanazawa University. Mice were anesthetized with sodium pentobarbital, killed by bleeding from the right atrium, and perfused transcardially in vivo with cold physiological saline. For RNA and protein extraction, the testes of mice were dissected out, frozen immediately in liquid nitrogen, and stored at Ϫ80ЊC until use. To make tissue specimens for immunohistochemistry, the animals were further perfused transaortally with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.2). The testes were dissected out, further immersed in the same fixative for 4 h, dehydrated in a graded alcohol series for 24 h, and embedded in paraffin. They were then cut into 4-mthick sections utilizing a routine procedure.
Preparation of Anti-SgIGSF Polyclonal Antibody
Polyclonal rabbit anti-SgIGSF serum was raised against a synthetic peptide corresponding to the C-terminal 15 amino acids (EGGQNNSEEK-KEYFI) of the cytoplasmic tail of mouse SgIGSF plus an additional cysteine residue at the C-terminus of the peptide [11] . The peptide was purchased from BEX (Tokyo, Japan), conjugated to keyhole limpet hemocyanin (Nakarai Tesque, Kyoto, Japan), and emulsified with an equal volume of Freund complete and incomplete adjuvants (Difco, Detroit, MI). It was then injected subcutaneously into three New Zealand White rabbits at 50 g in 1 ml every 2 wk for 4 mo. After confirming an increase in the levels of antibody titer to more than 5000ϫ, the whole blood was collected from each rabbit and the serum was separated. The IgG fraction was purified from the serum using Affi-Gel 10 beads (Bio-Rad Laboratories, Hercules, CA) conjugated with SgIGSF peptide and concentrated to approximately 100 g/ml.
Protein Preparation and Enzymatic Digestion of N-Linked Glycosylation
The mouse testes were homogenized in lysis buffer (1% Nonidet P40, 0.5% sodium deoxycholate, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and proteinase inhibitor cocktail; Roche, Mannheim, Germany). After centrifugation at 3000 rpm for 10 min, the supernatants were examined for the protein concentration using a BCA protein assay kit (Pierce, Rockford, IL) and used as cell lysates. Digestion of N-linked glycosylation sites was performed using PNGase F N-glycosidase (New England Biolabs, Beverly, MA) according to the manufacturer's instructions. The cell lysates from the testes at 20 g protein in 7.2 l were denatured with 0.8 l of denaturing buffer at 100ЊC for 10 min. They were then incubated with 1 l of G7 buffer, 10% NP-40, and 500 U/l of PNGase at 37ЊC for 1 h.
Western Blot Analysis
The cell lysates from mouse testes untreated or treated with the enzymatic deglycosylation were subjected to SDS-PAGE and transferred to PVDF membranes (Bio-Rad Laboratories). The blots were incubated with anti-SgIGSF (1:2000) or the antibody preabsorbed with the antigenic peptide. After washing, the blots were further incubated with horseradish peroxidase-labeled anti-rabbit IgG antibody (DAKO, Glostrup, Denmark) (1: 5000). The immunoreaction was detected with x-ray film after treatment of the blots with chemiluminescent reagent ECL-plus (Amersham Pharmacia Biotech, Uppsala, Sweden). After stripping, the blots were reprobed with anti-␣-tubulin antibody (Sigma-Aldrich, St. Louis, MO).
Immunoprecipitation
The cell lysate from 2-wk mouse testes containing 200 g protein was preabsorbed with protein-G-agarose for at least 3 h at 4ЊC. After centrifugation at 12 000 rpm for 20 sec, the supernatant was incubated with 10 g of anti-SgIGSF antibody for 1 h and further with protein-G-agarose for at least 3 h at 4ЊC. After centrifugation, the precipitate was washed twice with lysis buffer, twice with high-salt buffer (1% Nonidet P40, 0.5% sodium deoxycholate, 50 mM Tris-HCl, pH 7.5, 500 mM NaCl), and once with low-salt buffer (1% Nonidet P40, 0.5% sodium deoxycholate, 50 mM Tris-HCl, pH 7.5). The immunoprecipitated product was collected by centrifugation and resuspended in lysis buffer for the binding experiments or in SDS-PAGE sample buffer for electrophoresis.
Immunohistochemistry
The tissue sections of mouse testes were treated with 0.3% H 2 O 2 in methanol for 10 min to inhibit intrinsic peroxidase activity and with 5% normal goat serum for 30 min to prevent nonspecific antibody binding. Subsequently, the sections were incubated overnight at room temperature with anti-SgIGSF antibody at 1 g/ml. After the sections were washed in PBS, the sites of immunoreaction were visualized by incubating the sections successively with biotinylated horse anti-rabbit IgG antibody (Vector, Burlingame, CA) for 1 h, horseradish peroxidase-conjugated streptavidin (DAKO) for 1 h and 3Ј3Ј-diaminobenzidine tetrahydrochloride solution (Dojin, Osaka, Japan) containing H 2 O 2 for a few minutes. To confirm the specificity of the immunoreaction, the antibody was preabsorbed with the peptide antigen used for the immunization (10 g peptide for 1 g of IgG) for 1 h at 4ЊC prior to use. For immunoelectron microscopy, cryostat sections of the testes were prepared and immunostained in the same way as for paraffin sections. They were then fixed with 0.5% OsO 4 , stained with 1% uranyl acetate and embedded in Glicidether (Selva Feinbiochemica, Heidelberg, Germany). Ultrathin sections were prepared and subjected to observation with a Hitachi H-700 electron microscopy.
RNA Extraction and Northern Blot Analysis
The mouse testes were homogenized in a guanidine thiocyanate-containing mixture (RNAzol, Tel-Test, Friendswood, TX), and the total RNA was extracted according to the manufacturer's instruction. The poly(A) ϩ RNA was further purified from the total RNA using PolyATract mRNA Isolation System kit (Promega, Madison, WI). Northern blot analysis was performed as previously described [11] . Briefly, 2-g aliquots of the poly(A) ϩ RNA were denatured by glyoxal, electrophoresed, and blotted onto nylon membrane (Pall BioSupport, East Hills, NY) according to Thomas [12] . The membrane was hybridized with 32 P-labeled SgIGSF cDNA probe and exposed to Kodak BIOMAX MS film with intensifying screen at Ϫ80ЊC for autoradiography.
Cell Culture, Plasmid Construction, and Transfection COS-7 cells were maintained in Dulbecco modified eagle medium (DMEM)containing 10% fetal bovine serum at 37ЊC in 5% CO 2 . A cDNA fragment encompassing the entire coding sequence of SgIGSF was amplified by PCR using a 3Ј primer containing a Apa I restriction site (in bold) (5Ј-TTTGGGCCCGAGATGAAGTACTCTTTCTTTTC-3Ј) and a 5Ј primer (5Ј-TCTGAGGCAGGTGCCCGACA-3Ј). The resulting PCR fragment was cloned into pcDNA3.1/V5-His TOPO vector (Invitrogen) according to the manufacturer's protocol. The plasmid vector was digested with Apa I and ligated again to allow in-frame cloning of SgIGSF with the V5 epitope and polyhistidine tag. This mammalian expression vector, pcDNA3.1-SgIGSF/V5-His, was transfected into COS-7 cells using lipofectamin 2000 reagent (Invitrogen). Forty-eight hours after the transfection, the cells were collected and the cell lysate was prepared for the binding experiment and electrophoresis.
Sertoli Cell Primary Culture and the Binding Experiments
The isolation and primary culture of Sertoli cells from immature mouse testes were performed according to the methods reported by Dorrington et al. [13] with modifications. The reason we used the testes from 10-day mice was easiness of the culture of Sertoli cells. The testes were collected and decapsulated in Hanks balanced salt solution. They were incubated with 0.25% trypsin and 100 g/ml DNase I in Hanks solution with rigorous shaking at 32ЊC for 30 min. Seminiferous tubule fragments were collected by centrifugation at 400 rpm for 2 min and then incubated with 100 g/ml collagenase and 100 g/ml hyaluronidase at 32ЊC for 30 min to remove peritubular myoid cells. After centrifugation at 400 rpm, seminiferous tubule fragments were further incubated with 100 g/ml hyaluronidase at 32ЊC for 30 min to remove spermatogenic cells. Clumps of Sertoli cells containing spermatogenic cells were collected by centrifugation at 400 rpm and were dissociated vigorously in Ca 2ϩ , Mg 2ϩ -free Hanks solution using a Pasteur pipette. After centrifugation at 1200 rpm for 2 min, Sertoli cells were suspended in serum-free DMEM (Nissui, Tokyo, Japan) and cultured on coverslips placed in plastic dishes at 37ЊC in a humidified atmosphere of 5% CO 2 and 95% air. To remove contaminating spermatogenic cells, the cells were washed after a 1-day culture with 20 mM Tris-HCl, pH 7.0. The Sertoli cells were subjected to the binding experiment after a 4-day culture.
For the binding experiments, the cultured Sertoli cells on coverslips were fixed with cold 50% methanol and 50% acetone for 10 min, washed in PBS, and incubated in PBS containing 3% bovine serum albumin (Sigma-Aldrich) to avoid nonspecific binding. They were then incubated with anti-SgIGSF-immunoprecipitated products of 2-wk testis lysate or with the lysate of COS-7 cells transfected to express recombinant SgIGSF overnight at 4ЊC. We used 2-wk testis lysate to match the age of the Sertoli cells. The 2-wk mouse testis is known to contain spermatogenic cells up to the steps of primary spermatocyte [14] . After washing in PBS three ϩ RNA at 2 g/lane purified from the testes of mice at 1-6 wk and 10 wk were electrophoresed in agarose gel, blotted onto nylon membrane, and hybridized with 32 P-labeled cDNA probe for SgIGSF.
FIG. 2. Western blot analysis showing the expression of SgIGSF in the cell lysates of developing mouse testes before and after enzymatic deglycosylation.
A) The cell lysates from the testes of mice at 0-6 wk and 10 wk were electrophoresed in polyacrylamide gel, blotted onto PVDF membrane, and stained with anti-SgIGSF antibody. B) The same cell lysates as in A were treated for the enzymatic deglycosylation and then analyzed with anti-SgIGSF antibody. C) The same cell lysates as in A were analyzed with anti-␣-tubulin antibody.
times, the cells were incubated with 10% normal goat serum for 30 min to block nonspecific immunoreaction and then with rabbit anti-SgIGSF antibody at 1 g/ml for immunoprecipitated products or mouse anti-V5 epitope antibody at 1 mg/ml for the lysate of COS-7 cells in PBS at room temperature. After 1 h, the cells were washed in PBS and then incubated for 1 h with Allexa594-labeled anti-rabbit IgG or Allexa594-labeled antimouse IgG (Molecular Probes, Eugene, OR) at 1 mg/ml in PBS. The cells were counterstained at 100 ng/ml of BisBenzimide H 33258 (Hoechst 33258; Sigma-Aldrich). The cells were subjected to observation with immunofluorescent microscopy using a Axiovert S100 microscopy (Carl Zeiss, Oberkochen, Germany).
RESULTS
Expression of SgIGSF in the Developing Testis
Northern blot analysis of the poly(A) ϩ mRNA from the testes of developing mice demonstrated SgIGSF mRNA consisting of two species 4.5-and 2.1-kb in size [11] (Fig.  1) . No apparent changes in the number and intensity of the SgIGSF mRNA species were detected in the testes between 1 and 10 wk.
A polyclonal anti-SgIGSF antibody was raised against a synthetic peptide corresponding to the carboxy-terminal residues 430-445 of the predicted SgIGSF protein. Western blot analysis using this antibody and the cell lysates obtained from the testes of developing mice, 0 day to 10 wk in age, demonstrated multiple immunopositive protein bands in a broad molecular weight range of 80-130 kDa ( Fig. 2A) . When the antibody was preabsorbed with an excess of the peptide antigen, these immunopositive bands were completely eliminated (not shown). At 0 day, a very weak band of 95 kDa was detected. By 1 wk, the band had greatly increased in intensity and split to two sizes of 90 and 100 kDa. The larger band increased gradually in size, reaching 130 kDa around 4 wk, and subsequently remained at the same intensity and size until 10 wk. In contrast, the 90-kDa band was constant in size until 10 wk but decreased gradually in intensity from 3 to 10 wk. Moreover, an additional weak 80-kDa band appeared at 3 wk and continued to be present until 10 wk. Thus, the expression of SgIGSF protein in the testis seemed to be developmentally regulated. Considering the predicted molecular mass of SgIGSF of about 56 kDa [11] and the lack of developmental changes in the pattern of SgIGSF mRNA expression (Fig. 1) , it was suggested that the pattern of SgIGSF protein in the testis is not regulated transcriptionally but is regulated in a translational or posttranslational manner. We suspected that the heterogeneity in the apparent molecular mass of Sg-IGSF depends on the differential glycosylation of the same polypeptide backbone. By its amino acid sequence, SgIGSF was predicted to have five asparagine-linked glycosylation sites [11] . We performed enzymatic deglycosylation of SgIGSF with N-glycosidase F. Treatment with N-glycosidase F resulted in a shift of the mobility of SgIGSF in developing testes from multiple bands at 80-130 kDa to a sharp band at 70 kDa (Fig. 2B) . This 70-kDa band was present in all ages except 0 day. As all three bands observed before deglycosylation of SgIGSF reduced their molecular mass, they were proven to be the products of glycosylation in different degrees.
Localization of SgIGSF During Spermatogenesis
To confirm the cellular localization of SgIGSF, we performed immunohistochemistry in paraffin-embedded mouse testicular sections using anti-SgIGSF antibody (Fig.  3) . The immunostaining was located exclusively in the seminiferous tubules and was not detected in cells of the interstitial tissue (Fig. 3A) . Most seminiferous epithelia were immunostained at two separate portions, i.e., those near the base of seminiferous tubules and close to the lumen. The immunopositive cells near the base of seminiferous tubules represented spermatogonia and spermatocytes, whereas No reactivity is present in any portions. C) At stage I (I), the immunoreactivity is localized in the early pachytene spermatocytes (arrows) and step 13 spermatids (st13). D) At stages IV-V (IV-V), the immunoreactivity is localized in the intermediate/type B spermatogonia (arrow heads) and step 15 spermatids (st15). E) At stage VII (VII), the immunoreactivity is localized in the preleptotene spermatocytes (arrows), step 7 spermatids (st7), and step 16 spermatids (st16). Note that the type A spermatogonium (arrow head) is devoid of the immunoreactivity. F) At stage VIII (VIII), the immunoreactivity is localized in the preleptotene spermatocytes (arrows), step 8 spermatids (st8), and step 16 spermatids (st16). Note that Sertoli cells (arrow heads) are devoid of the immunoreactivity. G) At stage XI (XI), the immunoreactivity is localized in the zygotene spermatocytes (arrows) and step 11 spermatids (st11). H) At stage XII (XII), the immunoreactivity is localized in the zygotene spermatocytes (arrows) and step 12 spermatids (st12). A, B) Bar ϭ 50 m. C-H) Bar ϭ 25 m.
those close to the lumen represented elongating spermatids. Absorption of the antibody with the carboxyl-terminal peptide of SgIGSF used for immunization abolished the immunoreaction (Fig. 3B) . In the mouse testis, spermiogenesis, i.e., the differentiation of spermatids, is divided into 16 steps based on the progression of acrosomal formation in spermatids and, using these steps and the nuclear morphology of spermatogenic cells, the spermatogenesis is classified into 12 stages represented by different segments of seminiferous tubules [15] . At stages IV-V of spermatogenesis (Fig. 3D) , SgIGSF immunoreactivity first appeared in intermediate/type B spermatogonia located among the immunonegative type A spermatogonia near the base of the tubules. The immunoreactivity appeared stronger on the cell surface than in the cytoplasm of these cells. At stages VII-VIII (Fig. 3, E and F) , the immunoactivity reached the maximum in intensity in preleptotene spermatocytes and remained intense in leptotene/zygotene spermatocytes at stages IX-XII (Fig. 3, G and H) . The immunoreactivity maintained its intensity in the early pachytene spermatocytes at stage I (Fig. 3C ) but subsequently decreased and disappeared in middle pachytene spermatocytes after stages IV-V (Fig. 3D) . SgIGSF immunoactivity appeared again in the spermatids at step 7 that were undergoing acrosomephase spermiogenesis (Fig. 3E) . The immunoreactivity of spermatids was as intense as that of spermatocytes and was No immunoreactivity is present in the type A spermatogonium (Sg). C) In the elongating spermatids at step 9, the immunoreactivity is localized on the cell membrane. A-C) Bars ϭ 1 m. stronger on the cell surface than in the cytoplasm. During steps 13-16, i.e., the maturation phase, the spermatids lost their cytoplasmic volume. At the last step of this phase, step 16, when spermatids face the lumen of seminiferous tubules, the immunoreactivity rapidly increased, probably representing the condensation of the immunoreactive cytoplasm in accordance with the progress of spermiogenesis (Fig. 3, E and F) . Furthermore, the residual bodies, representing this spermatid cytoplasm engulfed finally by Sertoli cells, showed strong immunoreactivity (Fig. 3F) . On the other hand, the flagellar components of the elongating spermatids had no immunoreactivity.
Electron Microscopic Localization of SgIGSF
Ultrastructural localization of SgIGSF in the seminiferous tubules was examined by the pre-embedding immunoelectron microscopy (Fig. 4) . The immunoreactivity was located exclusively in spermatogenic cells and was never detected in Sertoli cells. Spermatocytes in earlier steps characterized by their large round nuclei with thin cords of condensed chromatin displayed the immunoreaction localized primarily on the cell membrane and also in the cytoplasm (Fig. 4, A and B) . The membrane immunoreactivity appeared to be distributed diffusely on all portions of cell membrane, and its association with any morphological structures such as desmosome-like junction and ectoplasmic specialization was not clear. Elongating spermatids at step 9 also displayed the immunoreactivity localized primarily on the cell membrane (Fig. 4C) . In contrast, type A spermatogonia, spermatocytes in later steps, and most round spermatids were devoid of the immunoreaction (Fig.  4, A and B) .
Localization of SgIGSF in the Developing Testis
SgIGSF expression was examined in the testes from the normal mice at 0, 1, 2, 3, 4, and 5 wk postpartum and from 10-wk WWv mice (Fig. 5) . In 0-day testes, in which all germ cells are known to be type A spermatogonia [14] , no immunoreaction with anti-SgIGSF antibody was observed in the seminiferous tubules. In 1-wk testes, in which intermediate and type B as well as type A spermatogonia are present, weak immunoreactivity was detected in some round cells located close to the lumen of seminiferous tubules (not shown). In 2-wk testes, in which primary spermatocytes have appeared as round cells with large nucleus in the luminal sites of seminiferous tubules [14] , the immunoreactivity with moderate intensity was observed in spermatogonia and spermatocytes (Fig. 5A) . In 3-4-wk testes, in which spermatogonia and spermatocytes in earlier steps are located in the basal sites of seminiferous tubules and spermatocytes in later steps and a few round spermatid (before step 7) in the luminal sites, the immunoreactivity was localized to the former but not to the latter (Fig. 5B) . In 5-wk testes, in which elongating spermatids (after step 7) have first appeared in the luminal sites, the immunoreactivity was also observed on the surface of elongating spermatids (Fig. 5C ). Throughout the postnatal development, Sertoli cells remained immunonegative for SgIGSF (Fig. 5, A-C) . In the testes of WWv mice, in which spermatogenesis is impaired because of the lack of c-kit product [16] , no immunoreactivity was observed in the Sertoli cells or the very few type A spermatogonia (Fig. 5D) . These results were in good agreement with the cellular localization of SgIGSF during the spermatogenesis obtained in adult mouse testes. 
Binding Activity of SgIGSF to Sertoli Cells
To explore the possible expression of specific receptor(s) for SgIGSF, we performed the primary culture of Sertoli cells from the testes of 10 day-old mice and examined whether anti-SgIGSF-immunoprecipitated product of 2-wk testis lysate and the lysate of COS-7 cells transfected with the plasmid containing SgIGSF can interact with the surface of Sertoli cells. The immunoprecipitated product of 2-wk testis lysate, after denaturation with SDS and dithiothreitol TT, formed an identical band of about 95 kDa with that of SgIGSF when probed with anti-SgIGSF antibody (Fig. 6A) . The undenatured immunoprecipitated product was then incubated with the methanol/acetone-fixed primary culture of Sertoli cells to allow in situ binding of SgIGSF to putative receptor molecule(s) on the cell surface. The immunoprecipitated product bound to Sertoli cells, as shown by immunostaining of the Sertoli cell surface with anti-SgIGSF antibody (Fig 6B) , whereas the cells incubated with anti-SgIGSF antibody alone were never immunostained (Fig. 6C) . As an internal control, the spermatogenic cells contaminated in the culture were immunostained with the antibody alone (Fig. 6C) . Similarly, the lysate of transfected COS-7 cells contained recombinant SgIGSF with V5 epitope attached to its carboxyl terminus on electrophoreses (Fig. 7, A and B) , as detected with both anti-SgIGSF and anti-V5 epitope antibody. This recombinant SgIGSF was shown to bind to the surface of Sertoli cells incubated with the lysate (Fig. 7C) . In contrast, Sertoli cells incubated with the lysate of untransfected COS-7 cells showed no recombinant SgIGSF on their surfaces (Fig. 7D) . adult and developing mouse testes that SgIGSF is expressed in the cells belonging to two separate populations, i.e., the early spermatogenic cells ranging from intermediate spermatogonia to early pachytene spermatocytes on one hand and elongating spermatids later than step 7 on the other. No SgIGSF immunoreactivity is detected in the spermatogenic cells between these two phases or in Sertoli cells. In all immunopositive cells, SgIGSF has been localized principally to the cell membrane, consistent with the structure of SgIGSF as adhesion molecule. We reported previously with in situ hybridization that SgIGSF mRNA is localized specifically to the early spermatogenic cells ranging from spermatogonia to zygotene spermatocytes. The present localization of SgIGSF protein in the early spermatogenic cells is consistent with the expression of SgIGSF mRNA in these cells. In contrast, the localization of SgIGSF protein in the elongating spermatids unaccompanied by detectable levels of SgIGSF mRNA may indicate that the transcription of SgIGSF mRNA terminates in the early steps of spermatocytes, whereas the translation of SgIGSF, once diminished, resumes in the elongated spermatids later than step 7 using the remaining mRNA. A similar split of transcription and translation is known for certain testis-specific nuclear proteins, including the transition proteins and the protamines [17] . In these proteins, the transcription of mRNA occurs in round spermatids and then ceases, whereas the translation of protein occurs as late as in elongating spermatids using the remaining mRNA. Recently, MC31/ CE9, one of the cell membrane molecules, was also shown to be translated during the late spermatogenesis using the remaining mRNA [18, 19] . As for the biological role of SgIGSF deduced from their immunohistochemical localization of SgIGSF, two possibilities can be considered. One is the binding of spermatogenic cells themselves and the another is the binding between spermatogenic cell and Sertoli cell. In the present study, we have examined the latter possibility. Both antiSgIGSF-immunoprecipitated product from the cell lysate of 2-wk testes and the recombinant SgIGSF produced in COS-7 cells with enforced expression have been shown to bind to the surface of Sertoli cells in primary culture. Taken together with the fact that Sertoli cells themselves express no SgIGSF, these results indicate that SgIGSF on spermatogenic cells binds to a certain receptor molecule(s) on Sertoli cells. In general, various adhesion molecules, including the members of the immunoglobulin superfamily, are known to bind to themselves (homophilic binding) or to other molecules (heterophilic binding) [20] . The present results suggest that SgIGSF functions at least in the binding of spermatogenic cell to Sertoli cell in a heterophilic manner.
DISCUSSION
Sertoli cells are considered to create a highly specialized microenvironment within the seminiferous tubules required for the synchronized differentiation of spermatogenic cells during spermatogenesis. The junctional complex formed near the base of Sertoli cells, which is composed of basal ectoplasmic specialization as well as tight, gap, and desmosome-like junctions, divides that microenvironment into two compartments, i.e., the basal and adluminal compartments [3] . N-cadherin has been known to be expressed by Sertoli cells and may be involved in that junctional complex [5, 6] . Spermatogonia, preleptotene, and leptotene spermatocytes are located in the basal compartment, while the spermatogenic cells later than zygotene spermatocytes are located in the adluminal compartment. The former cells are in contact with both the basement membrane and Sertoli cells, whereas the latter cells are in contact with only Sertoli cells, receiving the nutrition, hormones, and local factors exclusively from Sertoli cells. The mechanism by which the spermatogenic cells in the basal compartment pass through the Sertoli cell junctional complex and translocate to the adluminal compartment is unclear but may involve active interaction between premeiotic spermatogenic cells and Sertoli cells on their cell surface. Furthermore, in the last steps of spermatogenesis, the elongated spermatids are also considered to undergo active surface interaction with Sertoli cells in the course of the displacement of spermatid cytoplasm from the condensing nuclei, its casting off as residual body followed by its phagocytosis by Sertoli cells [21] . We have examined the epididymal sperm and found they do not express SgIGSF, suggesting that SgIGSF functions only in the spermatogenic cells within the seminiferous tubules (not shown).
As an adhesion molecule expressed in the spermatogenic cells, nectin 3, a member of immunoglobulin superfamily, was recently found to be localized on the cell membrane of elongating spermatids [22] . Interestingly, nectin 3 was shown to bind to nectin 2 located on the membrane of Sertoli cells, implying the involvement of nectin 2/nectin 3 in the interaction of elongated spermatids and Sertoli cells through a heterophilic mechanism. MC31/CE9, another member of the immunoglobulin superfamily, was also found to be localized on the cell membrane of elongating spermatids, but it has not been clear if MC31/CE9 binds to the surface of Sertoli cells [18, 19] . The present study has revealed SgIGSF as an adhesion molecule localized on the cell membrane of both early spermatogenic cells and elongating spermatids. Moreover, SgIGSF has been shown to bind to certain receptor molecule(s) on Sertoli cells that differs from SgIGSF itself, suggesting a heterophilic mechanism for the spermatogenic cell-Sertoli cell interaction. It is interesting to assume the involvement of SgIGSF in such phenomena as translocation of premeiotic spermatogenic cells from basal to adluminal compartments and casting off of residual body from elongated spermatids. The identification and isolation of the unknown receptor molecule for SgIGSF expressed on the surface of Sertoli cells are now in progress.
